Quick Answer
CYTOKINETICS INC reported Operating Income Loss of -$612.26 million for the year ending 2025.
- CYTOKINETICS INC showed a decrease of -14.2% in Operating Income Loss from 2024 to 2025.
- This data is from CYTOKINETICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: -$11.75 million | Q2 2011: -$13.65 million | Q3 2011: -$10.67 million | Q1 2012: -$9.94 million | Q2 2012: -$8.96 million | Q3 2012: -$10.07 million | Q1 2013: -$12.65 million | Q2 2013: -$15.07 million | Q3 2013: -$12.61 million | Q1 2014: -$8.77 million | Q2 2014: -$8.41 million | Q3 2014: -$6.00 million | Q1 2015: -$8.91 million | Q2 2015: -$10.59 million | Q3 2015: -$8.89 million | Q1 2016: -$11.95 million | Q2 2016: -$11.01 million | Q3 2016: $33.97 million | Q1 2017: -$23.25 million | Q2 2017: -$25.19 million | Q3 2017: -$28.42 million | Q1 2018: -$26.13 million | Q2 2018: -$23.41 million | Q3 2018: -$17.91 million | Q1 2019: -$24.52 million | Q2 2019: -$26.72 million | Q3 2019: -$23.93 million | Q1 2020: -$30.36 million | Q2 2020: -$32.36 million | Q3 2020: $5.18 million | Q1 2021: -$40.61 million | Q2 2021: -$54.80 million | Q3 2021: -$69.20 million | Q1 2022: -$77.86 million | Q2 2022: -$10.87 million | Q3 2022: -$108.44 million | Q1 2023: -$124.47 million | Q2 2023: -$122.05 million | Q3 2023: -$122.27 million | Q1 2024: -$126.24 million | Q2 2024: -$130.17 million | Q3 2024: -$140.80 million | Q1 2025: -$155.63 million | Q2 2025: -$111.51 million | Q3 2025: -$166.76 million.
- Over the full 17 years of available data (2009 to 2025), CYTOKINETICS INC's Operating Income Loss has declined by 2,446.3%.
- Historical annual values: Fiscal year 2025: -$612.26 million | Fiscal year 2024: -$536.25 million | Fiscal year 2023: -$496.21 million | Fiscal year 2022: -$324.20 million | Fiscal year 2021: -$186.31 million | Fiscal year 2020: -$93.94 million | Fiscal year 2019: -$98.87 million | Fiscal year 2018: -$88.92 million | Fiscal year 2017: -$113.40 million | Fiscal year 2016: $18.69 million | Fiscal year 2015: -$37.41 million | Fiscal year 2014: -$14.75 million | Fiscal year 2013: -$33.89 million | Fiscal year 2012: -$40.46 million | Fiscal year 2011: -$47.96 million | Fiscal year 2010: -$49.64 million | Fiscal year 2009: $26.10 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: